Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: other routes
Type of information:
experimental study
Adequacy of study:
supporting study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
study well documented, meets generally accepted scientific principles, acceptable for assessment

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1976
Report date:
1976

Materials and methods

Principles of method if other than guideline:
according to company-internal standard
GLP compliance:
no
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
N,N-diethyl-2-propynylamine
EC Number:
223-804-5
EC Name:
N,N-diethyl-2-propynylamine
Cas Number:
4079-68-9
Molecular formula:
C7H13N
IUPAC Name:
diethyl(prop-2-yn-1-yl)amine
Specific details on test material used for the study:
Name of the test substance used in the study report: Golpanol DEP = 1-Diethylaminopropin

Test animals

Species:
mouse
Strain:
NMRI
Remarks:
Ivanovas
Sex:
male/female
Details on test animals or test system and environmental conditions:
- Mean body weight: males: 27.2 g; females: 24.0 g
- The animals were offered a standardized animal laboratory diet (Altromin R 1324, Altromin GmbH, Lage, Germany)

Administration / exposure

Route of administration:
intraperitoneal
Vehicle:
CMC (carboxymethyl cellulose)
Details on exposure:
Emulsion in 0.5% aqueous CMC preparation with 2 - 3 drops Cremophor EL.
Test concentrations used: 2.15, 3.16, 4.64, 6.81 and 10% (V/V).
Doses:
215, 316, 464, 681 and 1000 µL/kg
No. of animals per sex per dose:
5
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight

Results and discussion

Effect levels
Key result
Sex:
male/female
Dose descriptor:
LD50
Effect level:
ca. 200 mg/kg bw
Remarks on result:
other: original value: ca. 250 µL/kg
Mortality:
215 µL/kg: no deaths after 14 days; 316 µL/kg: 8/10 after 14 days; 464 µL/kg: 7/10 after 14 days; 581 and 1000 µL/kg: 10/10 after 14 days
Clinical signs:
Dyspnea, apathy, abdominal and lateral position, staggering, trembling, twitching, partly jumping convulsions, partly clonic-tonic convulsions, poor general state.
Body weight:
Normal body weight growth.
Gross pathology:
No intra-abdominal substance residues, no adherences.

Applicant's summary and conclusion